Teresa Visit 2: Diagnosing and Treating Fibromyalgia


Teresa Visit 2: Diagnosing and Treating Fibromyalgia

Topic: Fibromyalgia
Relevant Terms: Pain Management
Primary Audience: Primary care providers (MDs/ DOs/ NPs/ PAs)
Launch Date: 06-Sep-11
Credits: 0.5 AMA PRA Category 1 Credit
0.5 NPWH contact hour
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Diagnosing and Treating Fibromyalgia

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Evaluate treatment response for patients with fibromyalgia
  2. Identify pharmacological and non-pharmacological treatment options for patients with fibromyalgia to provide evidence-based care
  3. Discuss patient-centered goals of therapy to enhance patient outcomes
  4. Design a comprehensive treatment program for a patient with fibromyalgia


    Lesley M. Arnold, MD
    Professor of Psychiatry and Behavioral Neuroscience
    Director, Women's Health Research Program
    University of Cincinnati College of Medicine
    Cincinnati, Ohio
    Anne Moore, APN, WHNP/ANP-BC, FAANP 
    Professor of Nursing 
    Vanderbilt University
    Nashville, TN
    Suzie As-Sanie, MD, MPH
    Assistant Professor
    The University of Michigan
    Department of Obstetrics and Gynecology
    Ann Arbor, MI
    Disclosure Policy Statement

    All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

    Faculty Disclosures

    • Anne Moore has no affliations to disclose
    • Lesley Arnold is a consultant for Eli Lilly, Pfizer, Cypress Bioscience, Forest, Astra Zeneca, Takeda, Sanofi Aventis, Grunenthal,,Johnson & Johnson and research investigator for Eli Lilly, Pfizer, Cypress Bioscience, Boehringer, Ingelheim, Forest, Novartis
    • Suzie As-Sanie has no affliations to disclose

    Staff/Consultant Disclosures

    • Deborah Kurnik, MBA, Ellen Cohen,  Cert.Ed., Dip.Ed., CCMEP, Beth Jordan, MD,  Lanita Williams, MPH, Amy Swann, MA, Shana Brown, MPH, Rebecca Sager and Wayne Shields have no affiliations to disclose.

    Credit Designation

    The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Nurse Practitioners and Nurses
    : This educational activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 0.5 contact hours, including up to 0.25 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.

    : A certificate of participation will be issued indicating that this activity is accredited for up to 0.5 hours of AMA PRA Category 1 Credit™.

    How to Receive Credit or a Certificate of Participation

    • Read the learning objectives and disclosures
    • Participate in the activity
    • Complete the post-test and activity evaluation
    • You must score a 70% or higher on the post-test and activity evaluation
    • Statement of credit will be available to print from your user history page

    ourse Viewing Requirements

    Internet Explorer (v6 or greater), or Firefox

    Commercial Support

    This project is funded through an educational grant from Pfizer, Inc.

    All site content, except where otherwise noted, is licensed under a Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/).